Aminoguanidine inhibits the AGE-RAGE axis to modulate the induction of periodontitis but has limited effects on the progression and recovery of experimental periodontitis: A preliminary study

Journal of Periodontology

Volumn 85, Issue 5, 2014, Pages 729-739

  Chang, Po Chun ^a   Chong, Li Yen ^b   Tsai, Sheng Chueh ^b,c   Lim, Lum Peng ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Advanced; Animal; Gene expression; Glycosylation end products; Inflammation; Models; Periodontitis; X ray microtomography

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; AMINOGUANIDINE; ANGIOGENIC FACTOR; BIOLOGICAL MARKER; CELL ADHESION MOLECULE; COLLAGEN TYPE 1; FIBRONECTIN; GUANIDINE DERIVATIVE; IMMUNOGLOBULIN RECEPTOR; NITRIC OXIDE SYNTHASE; PEROXIDASE; POSTN PROTEIN, RAT; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ALVEOLAR BONE LOSS; ANIMAL; ANTAGONISTS AND INHIBITORS; DISEASE COURSE; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; IMAGE PROCESSING; JAW; MALE; MICRO-COMPUTED TOMOGRAPHY; PATHOLOGY; PATHOPHYSIOLOGY; PERIODONTITIS; PERIODONTIUM; PHYSIOLOGY; PROCEDURES; RAT; SPRAGUE DAWLEY RAT; WOUND HEALING;

ALVEOLAR BONE LOSS; ALVEOLAR PROCESS; ANGIOGENESIS INDUCING AGENTS; ANIMALS; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FIBRONECTINS; GENE EXPRESSION REGULATION; GLYCOSYLATION END PRODUCTS, ADVANCED; GUANIDINES; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; NITRIC OXIDE SYNTHASE; PERIODONTITIS; PERIODONTIUM; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, IMMUNOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING; X-RAY MICROTOMOGRAPHY;

EID: 84896448175     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2013.130238     Document Type: Article

References (33)

1. Abbass MM, Korany NS, Salama AH, Dmytryk JJ, Safiejko-Mroczka B. The relationship between receptor for advanced glycation end products expression and the severity of periodontal disease in the gingiva of diabetic and non diabetic periodontitis patients. Arch Oral Biol 2012;57:1342-1354.
2. Lalla E, Lamster IB, Stern DM, Schmidt AM. Receptor for advanced glycation end products, inflammation, and accelerated periodontal disease in diabetes: Mechanisms and insights into therapeutic modalities. Ann Periodontol 2001;6:113-118.
3. Mealey BL, Oates TW; American Academy of Periodontology. Diabetes mellitus and periodontal diseases. J Periodontol 2006;77:1289-1303. (Pubitemid 44740584)
4. Lalla E, Lamster IB, Feit M, et al. Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. J Clin Invest 2000;105:1117-1124. (Pubitemid 30217696)
5. Chang PC, Chien LY, Yeo JF, et al. Progression of periodontal destruction and the roles of advanced glycation end products in experimental diabetes. J Periodontol 2013;84:379-388.
6. Chang PC, Chung MC, Wang YP, et al. Patterns of diabetic periodontal wound repair: A study using micro-computed tomography and immunohistochemistry. J Periodontol 2012;83:644-652.
7. Chang PC, Chien LY, Chong LY, Kuo YP, Hsiao JK. Glycated matrix up-regulates inflammatory signaling similarly to Porphyromonas gingivalis lipopolysaccharide. J Periodontal Res 2013;48:184-193.
8. Di Paola R, Marzocco S, Mazzon E, et al. Effect of aminoguanidine in ligature-induced periodontitis in rats. J Dent Res 2004;83:343-348. (Pubitemid 41713773)
9. Pacios S, Kang J, Galicia J, et al. Diabetes aggravates periodontitis by limiting repair through enhanced inflammation. FASEB J 2012;26:1423-1430.
10. Wu CH, Huang CM, Lin CH, Ho YS, Chen CM, Lee HM. Advanced glycosylation end products induce NF-kappaB dependent iNOS expression in RAW 264.7 cells. Mol Cell Endocrinol 2002;194:9-17.
11. Valcourt U, Merle B, Gineyts E, Viguet-Carrin S, Delmas PD, Garnero P. Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation. J Biol Chem 2007;282:5691-5703. (Pubitemid 47093757)
12. Aspriello SD, Zizzi A, Spazzafumo L, et al. Effects of enamel matrix derivative on vascular endothelial growth factor expression and microvessel density in gingival tissues of periodontal pocket: A comparative study. J Periodontol 2011;82:606-612.
13. Rios HF, Ma D, Xie Y, et al. Periostin is essential for the integrity and function of the periodontal ligament during occlusal loading in mice. J Periodontol 2008;79:1480-1490.
14. Kudo A. Periostin in fibrillogenesis for tissue regeneration: Periostin actions inside and outside the cell. Cell Mol Life Sci 2011;68:3201-3207.
15. Ghosh A, Park JY, Fenno C, Kapila YL. Porphyromonas gingivalis, gamma interferon, and a proapoptotic fibronectin matrix form a synergistic trio that induces c-Jun N-terminal kinase 1-mediated nitric oxide generation and cell death. Infect Immun 2008;76:5514-5523.
16. Chang PC, Liang K, Lim JC, Chung MC, Chien LY. A comparison of the thresholding strategies of micro-CT for periodontal bone loss: A pilot study. Dentomaxillofac Radiol 2013;42:66925194.
17. Garcia VG, Fernandes LA, Macarini VC, et al. Treatment of experimental periodontal disease with antimicrobial photodynamic therapy in nicotinemodified rats. J Clin Periodontol 2011;38:1106-1114.
18. Saed GM, Ali-Fehmi R, Jiang ZL, et al. Myeloperoxidase serves as a redox switch that regulates apoptosis in epithelial ovarian cancer. Gynecol Oncol 2010;116:276-281.
19. Dai C, Zheng CQ, Meng FJ, Zhou Z, Sang LX, Jiang M. VSL#3 probiotics exerts the anti-inflammatory activity via PI3k/Akt and NF-κB pathway in rat model of DSS-induced colitis. Mol Cell Biochem 2013;374:1-11.
20. Steffensen B, Duong AH, Milam SB, et al. Immunohistological localization of cell adhesion proteins and integrins in the periodontium. J Periodontol 1992;63:584-592.
21. Redlich K, Smolen JS. Inflammatory bone loss: Pathogenesis and therapeutic intervention. Nat Rev Drug Discov 2012;11:234-250.
22. Herrera BS, Martins-Porto R, Maia-Dantas A, et al. iNOS-derived nitric oxide stimulates osteoclast activity and alveolar bone loss in ligature-induced periodontitis in rats. J Periodontol 2011;82:1608-1615.
23. Nagai R, Murray DB, Metz TO, Baynes JW. Chelation: A fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications. Diabetes 2012;61:549-559.
24. Oates TW, Graves DT, Cochran DL. Clinical, radiographic and biochemical assessment of IL-1/ TNF-alpha antagonist inhibition of bone loss in experimental periodontitis. J Clin Periodontol 2002; 29:137-143. (Pubitemid 41697746)
25. Delima AJ, Oates T, Assuma R, et al. Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis. J Clin Periodontol 2001; 28:233-240. (Pubitemid 33755189)
26. Chen Y, Boettger MK, Reif A, Schmitt A, Ucxeyler N, Sommer C. Nitric oxide synthase modulates CFAinduced thermal hyperalgesia through cytokine regulation in mice. Mol Pain 2010;6:13.
27. Kamide T, Kitao Y, Takeichi T, et al. RAGE mediates vascular injury and inflammation after global cerebral ischemia. Neurochem Int 2012;60:220-228.
28. Nah SS, Choi IY, Lee CK, et al. Effects of advanced glycation end products on the expression of COX-2, PGE2 and NO in human osteoarthritic chondrocytes. Rheumatology (Oxford) 2008;47:425-431.
29. Andriankaja OM, Galicia J, Dong G, Xiao W, Alawi F, Graves DT. Gene expression dynamics during diabetic periodontitis. J Dent Res 2012;91:1160-1165.
30. Dulak J, Józkowicz A. Regulation of vascular endothelial growth factor synthesis by nitric oxide: Facts and controversies. Antioxid Redox Signal 2003;5:123-132.
31. Kolluru GK, Bir SC, Kevil CG. Endothelial dysfunction and diabetes: Effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med 2012; 2012:918267.
32. Lorente JA, Tejedor C, Delgado MA, et al. Hemodynamic, biochemical and morphological changes induced by aminoguanidine in normal and septic sheep. Intensive Care Med 2000;26: 1670-1680.
33. Goh SY, Cooper ME. Clinical review: The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 2008;93:1143-1152. (Pubitemid 351519698)